Q
QuantAbundanceAbundância, quantificada.

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,467 signal articles · 148 in last 24h · 154,238 total before filter · latest 1h ago
148last 24h
867last 7d
144● bullish (7d)
96● bearish (7d)
214publishers
AllMacro207Earnings107M&A125Regulatory21Product21Analyst18
✕ clear all filtersSentiment:bullishneutralbearishshow all (incl. clickbait)
Meta layoffs take disturbing turn in new lawsuit
TheStreet72d agobearish
Meta layoffs take disturbing turn in new lawsuit

There’s no sugarcoating it; getting laid off is awful. But if you've been following the news, it feels like tech workers are being laid off left and right. Here’s what one Reddit user, who was recently laid off from an account executive role at a tech company, had to say on the r/Layoffs subreddit: ...

JD.com (JD) Faces 618 False Advertising Probe As Investor Lawsuit Risk Builds
Simply Wall St.76d agobearish
JD.com (JD) Faces 618 False Advertising Probe As Investor Lawsuit Risk Builds

Chinese regulators have summoned JD.com over alleged false advertising during the recent 618 shopping festival. The scrutiny centers on how promotional offers and discounts were presented during one of China's key mid year sales events. Law firm Pomerantz LLP has launched a securities fraud investigation linked to this regulatory action on behalf of JD.com investors. JD.com, listed on the NasdaqGS under the ticker NasdaqGS:JD, now sits in the spotlight as regulators and investors assess the...

Meta business model in trouble from $1.4 trillion lawsuit
TheStreet77d agobearish
Meta business model in trouble from $1.4 trillion lawsuit

If you have ever caught yourself doom scrolling on Instagram or Facebook for hours on end and felt bad, don't; the technology is working exactly how it was intended to. Everything from the length and style of the Reels to the algorithms' encyclopedic knowledge of your likes and dislikes is designed ...

Amgen (AMGN) Recalls Put Its Valuation Story Back In Focus
Simply Wall St.79d agobearish
Amgen (AMGN) Recalls Put Its Valuation Story Back In Focus

Amgen (AMGN) has moved into focus after initiating voluntary nationwide recalls of certain Corlanor and Sensipar tablet lots due to foreign substances and CGMP deviations, prompting investors to reassess drug quality and compliance risks. See our latest analysis for Amgen. Against this recall backdrop, Amgen’s recent momentum has stayed intact, with a 30 day share price return of 5.30% and a year to date share price return of 12.35%. The 1 year total shareholder return of 27.66% and 3 year...

Eli Lilly price target boost, Vertex-Crinetics deal, Meta's new social media lawsuit
Yahoo Finance Video79d agobearishVIDEO
Eli Lilly price target boost, Vertex-Crinetics deal, Meta's new social media lawsuit

Market Domination Host Josh Lipton tracks several of the day's top trending stock tickers, including JPMorgan analysts raising their price target on Eli Lilly (LLY) stock, Vertex Pharmaceuticals' (VRTX) acquisition of Crinetics (CRNX), and the possible $1.4 trillion lawsuit that multiple states are now suing Meta Platforms (META) for.

Bloomberg79d agobearish
China Watchdog Monitoring US Lawsuit Over Insider Trading Claims

(Bloomberg) -- China’s securities regulator said it was monitoring developments in a US lawsuit after Susquehanna International Group alleged insider traders made at least $100 million from well-timed options bets before Beijing’s recent crackdown on illegal cross-border trading. Most Read from BloombergGreece Offers Bounty to Catch Ravenous Fish Lured by Warming SeaMicrosoft’s Xbox to Cut 3,200 Jobs, Divest Five Studios in Major OverhaulTwo Millennium Trading Pods Made About $3.7 Billion Last M